Immunological alternation in COVID-19 patients with cancer and its implications on mortality
Guangyao Cai, Yue Gao, Shaoqing Zeng, Yang Yu, Xingyu Liu, Dan Liu, Ya Wang, Ruidi Yu, Aakash Desai, Chunrui Li, Qinglei Gao
Abstract
: This study has been registered on the Chinese Clinical Trial Registry (No. ChiCTR2000032161).
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Alternation (linguistics)CancerMedicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunologyVirologyDiseaseInternal medicineInfectious disease (medical specialty)OutbreakPhilosophyLinguisticsCOVID-19 and healthcare impactsCOVID-19 Clinical Research StudiesCOVID-19 Impact on Reproduction